U.S. Markets closed

FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada -- CFN Media

SEATTLE, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (HUGE.CN) (FSDDF) (FFT:0K9). The company has recognized these trends and recently hired an insurance expert to plan out its approach ahead of its sales license that’s expected later this year.

Cannabis investors have been focused largely on the recreational market with the legalization of adult-use cannabis last year, but a growing body of research suggests that medical cannabis remains a compelling long-term opportunity. The biggest question mark has been surrounding insurance coverage, which could prove to be a game-changer by making medical cannabis a lot more affordable to a much wider patient population.

Canada’s Health Insurance Market

Canada has a public healthcare system that provides preventative care and medical treatment from primary care physicians along with access to hospitals and other medical services. While some prescription medications are available through public programs, most Canadians pay out of pocket or use private health insurance. Roughly two-thirds of Canadians have some kind of private health insurance for this reason.

Most private insurance companies don’t cover medical cannabis outright because it doesn’t have a Drug Identification Number, or DIN, which means that it’s not a fully-approved medicine. While they don’t provide outright coverage, many insurance companies do offer Health Care Spending Accounts, where money is set aside to cover expenses. The downside is that only a small minority of the population maintains these types of accounts.

The good news is that these trends are starting to change. For example, Sun Life Assurance Co., a major Canadian health insurance company, recently announced that it would add medical cannabis to its group benefits plan last year. The yearly maximums for the coverage will range from $1,500 to $6,000 with eligible symptoms that include cancer, multiple sclerosis, rheumatoid arthritis, HIV/AIDS, and palliative care.

FSD Pharma Targets Insurance Markets

FSD Pharma recently signed a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track record in personal injury law where he has been assisting people with using medical cannabis to cope with pain. Under the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage, and no fault benefits across Canada.

“We are very excited to engage Mr. Romano in advance of our anticipated sales license,” said FSD Pharma Executive Chairman and Interim CEO in the press release announcing the deal. “This is a very timely and important agreement for FSD Pharma to maximize the opportunities in the Canadian market for our products and fits well with our strategy of establishing the company as a leader in medical cannabis.”

As the company moves closer to obtaining a sales license, health insurance expertise could become invaluable in creating potential end markets. The company’s massive ~3.4 million sq. ft. former Kraft Foods facility is well positioned to not only enable significant cannabis cultivation levels, but also house processing, manufacturing, extraction, and research and development facilities to build incremental shareholder value.

Looking Ahead

FSD Pharma Inc. (HUGE.CN) (FSDDF) (FFT:0K9) recently hired a health insurance expert to help it navigate insurance coverage issues for medical cannabis patients. As Canada’s policies continue to evolve, these insurance coverages could play a big role in making medical cannabis more affordable to patients in need, and accelerating the growth of the industry as it works to address underserved medical needs.

For more information, visit the company’s website at www.fsdpharma.com.

Please follow the link to read the full article on CFN:

https://www.cannabisfn.com/fsd-pharma-explores-insurance-coverage-for-medical-cannabis-in-canada/

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
Flane@cannabisfn.com